TScan Therapeutics (TCRX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, acting as Chairman, with formal business limited to official agenda items.

• Directors, executive team, and representatives from Deloitte & Touche LLP and Goodwin Procter LLP recognized.

• Stockholders of record as of April 15, 2026, were eligible to vote, with meeting rules and procedures outlined.

Board and executive committee updates

• Two nominees, Katina Dorton and R. Keith Woods, were nominated for Class 2 director positions for a three-year term.

• No stockholder nominations for directors were received in advance.

Corporate governance

• Deloitte & Touche LLP was proposed for ratification as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Ratification of the auditor was presented as a matter of good corporate governance, though not required by bylaws.